Castres, France

Ronan Depoortere



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ronan Depoortere: Innovator in Aminocyclobutane Derivatives

Introduction

Ronan Depoortere is a notable inventor based in Castres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminocyclobutane derivatives. With a total of 2 patents to his name, his work focuses on innovative methods for preparing these compounds and their applications in human therapy.

Latest Patents

Ronan's latest patents include the invention of aminocyclobutane derivatives, which are particularly recognized for their role as NMDA receptor antagonists. These compounds have potential applications in treating various medical conditions. The patents detail the method of preparation and the therapeutic uses of these derivatives, showcasing Ronan's commitment to advancing medical science.

Career Highlights

Ronan is currently employed at Pierre Fabre Medicament, a company known for its dedication to pharmaceutical innovation. His work at this esteemed organization has allowed him to explore and develop groundbreaking therapeutic solutions. His contributions have been instrumental in enhancing the understanding and application of aminocyclobutane derivatives in medicine.

Collaborations

Ronan has collaborated with several talented individuals in his field, including Bernard Vacher and Elodie Blanc. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ronan Depoortere stands out as a significant figure in the realm of pharmaceutical inventions. His work on aminocyclobutane derivatives not only highlights his inventive spirit but also contributes to the advancement of medical therapies. His ongoing efforts continue to inspire and pave the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…